Frequent low-dose misoprostol for termination of second-trimester pregnancy

被引:6
作者
Dilbaz, S [1 ]
Caliskan, E [1 ]
Dilbaz, B [1 ]
Kahraman, BG [1 ]
机构
[1] SSK Ankara Matern & Womens Hlth Teaching Hosp, Dept Obstet & Gynecol, Ankara, Turkey
关键词
misoprostol; induction; abortion; second trimester;
D O I
10.1080/13625180410001696232
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To determine the efficacy of an application regimen of low-dose frequent misoprostol for second-trimester pregnancy termination. Methods A total of 250 women between 12 and 20 weeks of gestation who were scheduled for second-trimester pregnancy termination received 200 mug vaginal misoprostol followed by 100 mug oral misoprostol every 2 h until expulsion of the fetus. Mechanical cervical dilatation with a 16-French Foley balloon catheter was performed if no cervical dilatation was observed after 24 h. The main outcome measures were the delivery rate within 24 h and the factors influencing the interval between the onset of induction and abortion. Secondary outcome measures were the side-effects of the regimen and the total misoprostol dose required. Results With application of this protocol, 245 women (98%) delivered within 24 h of induction. The mean ( standard deviation) misoprostol dose used was 728 +/- 297 mug (200-2100 mug). Cox regression analysis revealed that vaginal spotting or nulliparity do not effect the induction-abortion time. On the other hand, using this regimen induction to abortion time tends to be longer in the presence of live fetuses (odds ratio (OR) = 0.45; confidence interval (CI) = 0.2-0.8; p = 0.008) and pregnancies with gestational age >16 weeks (OR = 0.59; CI = 0.4-0.8; p = 0.003) when compared with cases of in utero death and pregnancies with a gestational age of 12-13 weeks, respectively. Twenty-seven women (10.8%) experienced one or more side-effects attributable to misoprostol. Conclusion The 100-mug oral misoprostol every 2 h following 200 mug vaginal misoprostol is a highly effective protocol for inducing abortion at 12-20 weeks of pregnancy. Cases with live fetuses or pregnancies with older gestational age (>16 weeks) deliver in a longer time period.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 23 条
[1]   The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration [J].
Abdel-Aleem, H ;
Villar, J ;
Gülmezoglu, AM ;
Mostafa, SA ;
Youssef, AA ;
Shokry, M ;
Watzer, B .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 108 (01) :25-28
[2]   Uterine rupture in second trimester abortion in a grand multiparous woman - A complication of misoprostol and oxytocin [J].
Al-Hussaini, TK .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 96 (02) :218-219
[3]   Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases [J].
Ashok, PW ;
Templeton, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (07) :706-710
[4]   A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy [J].
Bartley, J ;
Baird, DT .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (11) :1290-1294
[5]   A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination [J].
Bebbington, MW ;
Kent, N ;
Lim, K ;
Gagnon, A ;
Delisle, MF ;
Tessier, F ;
Wilson, RD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (04) :853-857
[6]   Uterine rupture during second-trimester abortion associated with misoprostol [J].
Berghahn, L ;
Christensen, D ;
Droste, S .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (05) :976-977
[7]   Oral misoprostol for the third stage of labor:: A randomized controlled trial [J].
Çaliskan, E ;
Dilbaz, B ;
Meydanli, MM ;
Öztürk, N ;
Narin, MA ;
Haberal, A .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (05) :921-928
[8]   A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death [J].
Chittacharoen, A ;
Herabutya, Y ;
Punyavachira, P .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (01) :70-73
[9]   Comparison between oral and vaginal administration of misoprostol on uterine contractility [J].
Danielsson, KG ;
Marions, L ;
Rodriguez, A ;
Spur, BW ;
Wong, PYK ;
Bygdeman, M .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (02) :275-280
[10]   A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality [J].
Dickinson, JE ;
Evans, SF .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (06) :1294-1299